American Society of Addiction Medicine. (2020) ASAM Public policy statement on e-cigarettes. Rockville, MD: American Society of Addiction Medicine.
External website: https://www.asam.org/advocacy/public-policy-statem...
Recommendations:
- Considering the rapidly changing regulatory landscape, emerging research, and continued controversy, the American Society of Addiction Medicine recommends:
- That all substances and behaviors involved with addiction, including nicotine, be included in the medical care plan of treatment in all treatment settings.
- That the FDA accelerate and intensify the regulation of e-cigarettes and e-fluids as tobacco products including ingredients and delivery systems to include specified nicotine concentration and standardized manufacturing techniques.
- That the FDA's enforcement of the 21-year-old minimum age for purchase of e-cigarettes be closely monitored to ensure compliance. Advertising campaigns discouraging e-cigarette use by youth should be disseminated to complement the FDA’s efforts to enforce this age requirement.
- That taxes be applied to e-cigarettes comparable to other tobacco products. Tax revenue obtained from these sources should be earmarked for public health prevention and treatment efforts.
- That e-cigarette flavors be prohibited unless a flavor has been demonstrated to help current tobacco users to stop smoking, will not lead non-tobacco users to start, and does not increase risk of harm from using the product.
- That the FDA create specific rules to continuously monitor and limit marketing tactics, particularly those that target children and young people, including flavors and cartoon themes, etc.
- That the use of e-cigarettes be prohibited in places defined by statute or regulation as tobacco-free environments.
That there be continued and increased research into the long-term potential for harms from the use of e-cigarettes and the component parts of their delivery system. - That research be expanded and accelerated on the potential for e-cigarettes, in particular for those who have not been able to quit or not interested in quitting, to be used as a potential tool in the treatment for nicotine/tobacco use and especially addiction involving nicotine, or as a component of a comprehensive harm reduction strategy.
Item Type
Report
Publication Type
International, Guideline
Drug Type
Tobacco / Nicotine
Intervention Type
Harm reduction, Policy
Date
April 2020
Publisher
American Society of Addiction Medicine
Corporate Creators
American Society of Addiction Medicine
Place of Publication
Rockville, MD
EndNote
Subjects
B Substances > Tobacco (cigarette smoking) > Nicotine product (e-cigarette / vaping / heated)
G Health and disease > State of health
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
N Communication, information and education > Recommendations > Practice / clinical guidelines
VA Geographic area > United States
G Health and disease > State of health
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
N Communication, information and education > Recommendations > Practice / clinical guidelines
VA Geographic area > United States
Repository Staff Only: item control page